Stay updated on CD19/22 CAR T Cells in DLBCL Clinical Trial
Sign up to get notified when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.

Latest updates to the CD19/22 CAR T Cells in DLBCL Clinical Trial page
- Check3 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check31 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.SummaryDifference0.2%

- Check45 days agoChange DetectedThe study page now renders a 403 Forbidden error page with a header and a Home button, replacing the detailed study information. This indicates the study record is currently inaccessible on ClinicalTrials.gov.SummaryDifference20%

- Check52 days agoChange DetectedThe page shows a revision tag updated from v3.6.6 to v3.7.0. This reflects a backend/template upgrade rather than changes to the study details or user-facing content.SummaryDifference0.0%

- Check66 days agoChange DetectedThe page revision label was updated from v3.6.5 to v3.6.6, indicating a new release of the page. This likely reflects minor fixes or template updates rather than changes to the study data or narrative.SummaryDifference0.0%

Stay in the know with updates to CD19/22 CAR T Cells in DLBCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/22 CAR T Cells in DLBCL Clinical Trial page.